Angelo Curto Pelle

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

A. Frustaci, M. Deodato, G. Zamprogna, 2022, Therapeutic advances in hematology.

Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation

G. Milone, S. Leotta, G. Milone, 2020, Frontiers in Immunology.

Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy

L. Villari, C. Conticello, G. Milone, 2019, Chemotherapy.

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

V. Rossi, A. Frustaci, M. Deodato, 2021, Blood advances.